All In Biotech

Drug Trial Radar · NCT01854658

Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD (PINNACLE 2)

A Randomized, Double-Blind (Test Products and Placebo), Chronic Dosing (24 Weeks), Placebo-Controlled, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD, Compared With Placebo

Last checked: Nov 19, 2026Latest source record: Mar 28, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,615 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,615

Actual

Start

Jul 2013

Primary completion

Mar 2015

Study completion Mar 2015

Sponsor

Lead sponsor
Pearl Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
May 15, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 40 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, randomized, double-blind, parallel group, chronic-dosing (24 weeks), placebo-controlled study to assess the efficacy and safety of Glycopyrrolate (GP and Formoterol Fumarate (FF) combination metered-dose inhaler (MDI) (GFF; PT003), GP MDI (PT001), and FF MDI (PT005) compared with Placebo MDI in subjects with moderate to very severe COPD.

Conditions

  • Chronic Obstructive Pulmonary Disease (COPD)

Interventions

  • GFF MDI (PT003)Drug

    GFF MDI administered as two puffs BID

  • GP MDI (PT001)Drug

    GP MDI administered as two puffs BID

  • FF MDI (PT005)Drug

    FF MDI administered as two puffs BID

  • PlaceboDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Morning Pre-dose Trough FEV1Time frame: At Week 24

Locations

113 sites in 1 country. Site status is shown where the registry gives one.

  • Pearl Investigative Site

    Birmingham, Alabama

  • Pearl Investigative Site

    Florence, Alabama

  • Pearl Investigative Site

    Jasper, Alabama

  • Pearl Investigative Site

    Mobile, Alabama

  • Pearl Investigative Site

    Fullerton, California

  • Pearl Investigative Site

    Gold River, California

  • Pearl Investigative Site

    Long Beach, California

  • Pearl Investigative Site

    Los Angeles, California

  • Pearl Investigative Site

    Mission Hills, California

  • Pearl Investigative Site

    Newport Beach, California

  • Pearl Investigative Site

    North Hollywood, California

  • Pearl Investigative Site

    Northridge, California

  • Pearl Investigative Site

    Rancho Mirage, California

  • Pearl Investigative Site

    Rialto, California

  • Pearl Investigative Site

    Rolling Hills Estates, California

  • Pearl Investigative Site

    San Diego, California

  • Pearl Investigative Site

    Santa Monica, California

  • Pearl Investigative Site

    Stockton, California

  • Pearl Investigative Site

    Torrance, California

  • Pearl Investigative Site

    Wildomar, California

  • Pearl Investigative Site

    Centennial, Colorado

  • Pearl Investigative Site

    Boynton Beach, Florida

  • Pearl Investigative Site

    Clearwater, Florida

  • Pearl Investigative Site

    Hialeah, Florida

  • Pearl Investigative Site

    Jacksonville, Florida

  • Pearl Investigative Site

    Kissimmee, Florida

  • Pearl Investigative Site

    Melbourne, Florida

  • Pearl Investigative Site

    Miami, Florida

  • Pearl Investigative Site

    New Port Richey, Florida

  • Pearl Investigative Site

    Orlando, Florida

  • Pearl Investigative Site

    Ormond Beach, Florida

  • Pearl Investigative Site

    Port Orange, Florida

  • Pearl Investigative Site

    Sanford, Florida

  • Pearl Investigative Site

    Sebring, Florida

  • Pearl Investigative Site

    Tamarac, Florida

  • Pearl Investigative Site

    Winter Park, Florida

  • Pearl Investigative Site

    Lawrenceville, Georgia

  • Pearl Investigative Site

    Norcross, Georgia

  • Pearl Investigative Site

    Smyrna, Georgia

  • Pearl Investigative Site

    Elk Grove, Illinois

Showing 40 of 113 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.